Related Experiment Videos

The oncogenicity of Jun

P K Vogt1, I M Morgan, L Håvarstein

  • 1Department of Microbiology, University of Southern California School of Medicine, Los Angeles 90033-1054.

Leukemia
|January 1, 1992
PubMed

Insights

Mutational analysis of the Jun protein reveals an inverse relationship between its transforming and transactivation abilities. This suggests Jun may gain oncogenicity through a loss of function, impacting cellular differentiation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Biology

Background:

  • The Jun protein is a key transcription factor involved in various cellular processes.
  • Understanding the mechanisms of Jun's oncogenic potential is crucial for cancer research.

Purpose of the Study:

  • To investigate the relationship between the transforming and transactivation potential of Jun protein mutants.
  • To explore the role of functional loss versus gain in Jun's oncogenicity.

Main Methods:

  • Mutational analysis of the delta region of the Jun protein.
  • Assessing transforming and transactivation potential in chicken embryo fibroblasts.
  • Evaluating the effect of Jun on the differentiation control element MyoD.
  • Analyzing chimeric proteins of Jun with JunD and herpes simplex VP16.

Main Results:

  • An inverse correlation was observed between the transforming and transactivation potential of Jun mutants.
  • Jun was found to downregulate the differentiation control element MyoD.
  • Highly transforming chimeric proteins of Jun exhibited low transactivating potential.

Conclusions:

  • Jun's oncogenicity may arise from a loss of function rather than a gain of function.
  • These findings challenge the understanding of positive and negative transcriptional control signals mediated by Jun.

Related Concept Videos